Navigation Links
Sinovac Reports Unaudited Second Quarter 2011 Financial Results
Date:8/12/2011

ce good immune responses.
  • In June 2011, Sinovac commenced the Phase II clinical trial for its proprietary inactivated EV71 vaccine against hand, foot and mouth disease. The Phase II clinical trial is designed as a single center, randomization, double blinded, and placebo controlled study.  The objective of the Phase II clinical trial is to determine the dosage level by evaluating the immunogenicity and safety with different level of dosages of Sinovac's EV71 vaccine candidate, and to provide reference data for Phase III clinical trial.

  • Dr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "Demand for our hepatitis vaccines is rebounding in China as demonstrated by our second quarter sales.  We are gaining traction in the public market as we recently received two provincial government orders in additional to our ongoing public market sales activity in Beijing, Shanghai, Tianjin and part of Jiangsu. This shows that our revised sales strategy focused on the public market and restructured sales team is producing favorable results. We will continue to strengthen our efforts in public market presence, and stabilize sales in the private market."

    Dr. Yin continued, "Over the past quarter, we have made substantial progress with our vaccine development pipeline. Our Phase II trial for our EV71 vaccine is progressing on schedule as dosing is underway and is on track to be completed within the year as planned.  We are optimistic about the potential for this vaccine as inquiries are increasing across Asia in the face of the current epidemic in Vietnam.  The registration for animal rabies vaccine is moving forward on schedule, which is anticipated to be launched within the year."

    Dr. Yin continued, "We are excited to obtain the Mexico GMP certificate for our seasonal flu and hepatitis A vaccines.  This is the significant milestone as we advance our global commercialization strategy to register our vaccines.
    '/>"/>

    SOURCE Sinovac Biotech Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Sinovac Announces Management Changes
    2. Sinovac Holds 2011 Annual Shareholders Meeting
    3. Sinovac Appoints Kenneth Lee to Board of Directors
    4. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
    5. Sinovac Reports Unaudited First Quarter 2011 Financial Results
    6. Sinovac Presents at Two Investor Conferences in May 2011
    7. Sinovac Files Annual Report on Form 20-F
    8. Sinovac Participates in UBS Greater China Healthcare Corporate Day
    9. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
    10. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
    11. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/3/2015)... 3, 2015  GenVec, Inc. (NASDAQ: GNVC ) ... T. Curiel and his team from the School ... Louis (WUSTL).  Dr. Curiel is the director ... Division within the Department of Radiation Oncology. ... will create modified versions of GenVec,s gorilla adenovectors that ...
    (Date:6/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/ssvbft/europe_ultrasound ) has announced the ... Growth, Trends And Forecasts (2014 - 2019)" report ... is dominated by the likes of UK followed by ... Germany . This can be attributed ... regions. The European Ultrasound devices market can ...
    (Date:6/2/2015)... 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... commercialization of products for the treatment of central nervous ... , M.D., Vanda,s President and CEO, will deliver a ... New York City on Thursday, ... The presentation at the Jefferies Global Healthcare Conference ...
    Breaking Medicine Technology:GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4European Ultrasound Devices Market Report 2015-2019 2
    ... DIEGO, Calif., May 18, 2012  Not all discount dental ... and CEO at First Dental Health . Unexpected fees ... by surprise. In addition, some discount dental plan specialists, fee ... all plans are licensed in the states where they operate. ...
    ... 2012  Receptos Inc. today announced that company personnel will ... Digestive Disease Week (DDW) annual meeting at 9 a.m. ... Diego Convention Center in San Diego, California. DDW attracts ... world to share the latest research in gastrointestinal health ...
    Cached Medicine Technology:Consumers Are Advised to Be Aware of Hidden Costs in Some Discount Dental Plans 2Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease 2
    (Date:6/3/2015)... June 03, 2015 Justina Molzon, MS ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Excellence in Service Award that recognizes the “Member ... a DIA volunteer and who has contributed to the ...
    (Date:6/3/2015)... 2015 Z-Medica®, LLC, a leading developer ... has been designated as National Safety Month by the ... Police Department for its commitment to public safety. ... Individual First Aid Kits (IFAK) over 100 times in ... stabbings or traffic accidents. Each kit is equipped with ...
    (Date:6/3/2015)... The panel of independent experts has spent weeks ... for the awards presented tonight at TU-Automotive Detroit 2015. ... the best-of-the-best can now be revealed as: , Car ... swept rivals aside by taking the coveted Car Maker ... our panel of expert judges., Stand out comments included: ...
    (Date:6/3/2015)... (PRWEB) June 03, 2015 For the fourth ... ( http://myclassifiedads.net ), a full-service advertising agency, has been honored ... Chamber of Commerce. , MCA has been selected as a ... The company will be honored at a luncheon sponsored by ... the Tampa Museum of Art. , “This luncheon will include ...
    (Date:6/3/2015)... TN (PRWEB) June 03, 2015 According ... Inquisitr police officers intercepted fake oxycodone pills which ... pills were doctored to look legitimate, and even sported ... officers are warning those consuming 30 mg oxycodone to ... the pills online or buy them illegally on the ...
    Breaking Medicine News(10 mins):Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3
    ... in ovarian cancer has provided the most comprehensive and integrated ... Ovarian serous adenocarcinoma tumors from 500 patients were examined by ... reported in the June 30, 2011, issue of Nature ... of ovarian cancer, accounting for about 85 percent of all ...
    ... (HealthDay News) -- Obesity is a major risk factor ... women, a new study finds. It included more than ... smoked and were followed for 28 years. During that time, ... disease and 487 (27 percent) from cancer. Researchers found ...
    ... recent study accepted for publication in The Endocrine Society,s ... early, prolonged treatment with the diabetes drug metformin may prevent ... adolescence. PCOS affects 7 to 10 percent of ... of infertility, affecting an estimated 5 to 6 million women ...
    ... Reporter , TUESDAY, June 28 (HealthDay News) -- A vaccine ... some promise, while another designed to alter insulin production fails, ... results of both studies were slated to be presented Tuesday ... Type 1 diabetes often appears early in life and ...
    ... are teaming up to offer one of the nation,s ... trucks. Led by the University of Maryland and ... program will target the so-called short-haul "drayage" fleet that ... The effort seeks to double the impact ...
    ... TUESDAY, June 28 (HealthDay News) -- Mammography screening reduces breast ... according to a new, large-scale Swedish trial. In a ... longest ever -- the researchers found that the benefits of ... In fact, most of the benefits occur more than 10 ...
    Cached Medicine News:Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 2Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 3Health News:Obesity a Major Cause of Early Death in Women: Study 2Health News:Diabetes drug may prevent or delay development of polycystic ovary syndrome 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 3Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 2Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 3Health News:Longest Trial Ever Confirms Mammograms' Benefits 2Health News:Longest Trial Ever Confirms Mammograms' Benefits 3
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: